Oral Lactoferrin to Prevent Nosocomial Sepsis and Necrotizing Enterocolitis of Premature Neonates and Effect on T-Regulatory Cells

Abstract

Objective Lactoferrin (LF) is effective in the prevention of sepsis in very low birth weight (VLBW) neonates. T-regulatory cells (Tregs) are important subsets of T lymphocytes that control pathogen-specific immune responses and are essential for intestinal immune homoeostasis. The aim of the present study is to determine whether oral LF at a dosage of 200 mg/d reduces nosocomial sepsis episodes and necrotizing enterocolitis (NEC) in premature infants and to evaluate the possible effects of LF on Treg levels.

Study Design In this prospective, placebo-controlled, double-blind, randomized trial, infants either VLBW or born before 32 weeks were assigned to receive either placebo (n = 25), or 200 mg LF (n = 25) daily throughout hospitalization. Episodes of culture proven nosocomial sepsis and NEC were recorded. The level of FOXP3 + CD4 + CD25hi lymphocytes was studied by flow cytometry at birth and discharge. A third comparison was made with healthy term neonates (n = 16).

Results Fewer sepsis episodes were observed in LF-treated infants (4.4 vs. 17.3/1,000 patient days, p = 0.007) with none developing NEC, without statistical significance. Treg levels at birth and discharge were similar, while preterm infants showed significantly lower levels than term controls. However, individual increases in Treg levels were higher in the LF group.

Conclusion LF prophylaxis reduced nosocomial sepsis episodes. Treg levels in preterm infants were lower than in term infants and an increase of Treg levels under LF prophylaxis was observed. Increase in Treg levels can be the mechanism for protective effects of LF on nosocomial sepsis.

Keywords

lactoferrin - VLBW - sepsis - NEC - T-regulatory lymphocytes

Note

Oral lactoferrin prophylaxis to prevent sepsis and necrotizing enterocolitis of very low birth weight neonates in neonatal intensive care unit and effect on T-regulatory cells (NCT01287507).

• References

• 1 Borghesi A, Tzialla C, Decembrino L, Manzoni P, Stronati M. New possibilities of prevention of infection in the newborn. J Matern Fetal Neonatal Med 2011; 24 (Suppl. 02) 28-30
• 2 Rønnestad A, Abrahamsen TG, Medbø S , et al. Late-onset septicemia in a Norwegian national cohort of extremely premature infants receiving very early full human milk feeding. Pediatrics 2005; 115 (3) e269-e276
• 3 Sisk PM, Lovelady CA, Dillard RG, Gruber KJ, O'Shea TM. Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol 2007; 27 (7) 428-433
• 4 Sullivan S, Schanler RJ, Kim JH , et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 2010; 156 (4) 562-567 , e1
• 5 Hirai Y, Kawakata N, Satoh K , et al. Concentrations of lactoferrin and iron in human milk at different stages of lactation. J Nutr Sci Vitaminol (Tokyo) 1990; 36 (6) 531-544
• 6 González-Chávez SA, Arévalo-Gallegos S, Rascón-Cruz Q. Lactoferrin: structure, function and applications. Int J Antimicrob Agents 2009; 33 (4) e1-e8
• 7 Jenssen H, Hancock RE. Antimicrobial properties of lactoferrin. Biochimie 2009; 91 (1) 19-29
• 8 Buccigrossi V, de Marco G, Bruzzese E , et al. Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation. Pediatr Res 2007; 61 (4) 410-414
• 9 Manzoni P, Rinaldi M, Cattani S , et al; Italian Task Force for the Study and Prevention of Neonatal Fungal Infections, Italian Society of Neonatology. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 2009; 302 (13) 1421-1428
• 10 Agace WW. T-cell recruitment to the intestinal mucosa. Trends Immunol 2008; 29 (11) 514-522
• 11 Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2 (9) 816-822
• 12 Manzoni P, Mostert M, Stronati M. Lactoferrin for prevention of neonatal infections. Curr Opin Infect Dis 2011; 24 (3) 177-182
• 13 Manzoni P, Stolfi I, Messner H , et al; Italian Task Force for the Study and Prevention of Neonatal Fungal Infections–the Italian Society of Neonatology. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics 2012; 129 (1) 116-123
• 14 Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16 (3) 128-140
• 15 Haque KN. Definitions of bloodstream infection in the newborn. Pediatr Crit Care Med 2005; 6 (3) S45-S49
• 16 Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986; 33 (1) 179-201
• 17 Banham AH, Powrie FM, Suri-Payer E. FOXP3+ regulatory T cells: Current controversies and future perspectives. Eur J Immunol 2006; 36 (11) 2832-2836
• 18 Steinborn A, Engst M, Haensch GM , et al. Small for gestational age (SGA) neonates show reduced suppressive activity of their regulatory T cells. Clin Immunol 2010; 134 (2) 188-197
• 19 Weitkamp JH, Rudzinski E, Koyama T , et al. Ontogeny of FOXP3(+) regulatory T cells in the postnatal human small intestinal and large intestinal lamina propria. Pediatr Dev Pathol 2009; 12 (6) 443-449
• 20 Weitkamp JH, Koyama T, Rock MT , et al. Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. Gut 2013; 62 (1) 73-82
• 21 Maul J, Loddenkemper C, Mundt P , et al. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 2005; 128 (7) 1868-1878
• 22 Lühn K, Simmons CP, Moran E , et al. Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection. J Exp Med 2007; 204 (5) 979-985
• 23 Kaufman DA. Lactoferrin supplementation to prevent nosocomial infections in preterm infants. JAMA 2009; 302 (13) 1467-1468